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This study found infrequent transmission of severe
acute respiratory syndrome (SARS) coronavirus to health-
care workers involved in the care of the first five case-
patients in Taiwan, despite a substantial number of
unprotected exposures. Nonetheless, given that SARS has
been highly transmissible on some occasions, we still rec-
ommend strict precautions.
H
ealthcare workers may be unwittingly exposed to the
severe acute respiratory syndrome–associated coron-
avirus (SARS-CoV) from patients with pneumonia at the
onset of an epidemic (1,2). They are also at increased risk
of acquiring SARS from known case-patients with a high
viral load who require intensive respiratory care (1–3). The
first case-patient in Taiwan was admitted to National
Taiwan University Hospital on March 8, 2003, before the
World Health Organization (WHO) issued the first global
alert (4,5). The patient was intubated in the emergency
room and was admitted to the intensive care unit. The sec-
ond case-patient, his wife, was admitted to the emergency
room with pneumonia on March 14. The occurrence of two
cases of pneumonia in the same household within 6 days,
together with the patients’ recent travel to Guangdong,
China, through Hong Kong, led us to suspect a diagnosis
of atypical pneumonia, which later came to be known as
SARS. 
Before the second case was detected, healthcare work-
ers routinely used standard precautions. Specific infection-
control measures, including droplet and contact
precautions against SARS, were implemented after the
second patient was admitted. The efficacy of these infec-
tion-control measures in protecting healthcare workers
was determined by: 1) the occurrence of SARS symptoms
as defined by WHO criteria (6) and 2) a rise in antibodies
to SARS-CoV before and after specific infection-control
measures were implemented.
The Study
From March 8 to March 28, the hospital admitted five
patients in whom SARS-CoV infection was subsequently
laboratory-confirmed. The patients were isolated in nega-
tive-pressure rooms. Patients 2 and 3 were family mem-
bers of patient 1. Patients 4 and 5 were believed to have
contracted SARS on a March 15 flight from Hong Kong to
Beijing. Four of the patients progressed rapidly to respira-
tory failure and were intubated. 
Healthcare workers caring for these patients were
exposed during two periods. During March 8–14, before
specific infection-control precautions were implemented,
73 healthcare workers were exposed to patients 1 and 2.
During March 15–28, after specific precautions were
implemented, an additional 150 healthcare workers were
exposed to all five patients.
All healthcare workers who had contact with SARS
patients used personal protective equipment, including
gown, gloves, N95 respirators, disposable cap, and shoe
covers. Healthcare workers exposed to SARS patients or
their environments were monitored for signs or symptoms
of SARS for 14 days after the last exposure. Healthcare
workers who had high-risk exposures to SARS were
excluded from new duty assignments. We considered per-
forming any of the following to be a high-risk exposure:
endotracheal intubation >30 min, cardiopulmonary resus-
citation >30 min, pleurocentesis >30 min, or bedside care
(such as chest care [including percussion and postual
drainage] or feeding) >30 min. Any healthcare worker in
whom fever developed (temperature >38°C) was isolated
in a specially designated ward. 
A total of 223 healthcare workers exposed to SARS
patients were interviewed by one of two researchers with a
structured questionnaire designed by the Centers for
Disease Control and Prevention (CDC), USA, and the
Center for Disease Control, Taiwan. The following data
were recorded on uniform case-report sheets: extent of per-
sonal protective equipment use during exposure, type of
exposure (stay in the same room, direct patient contact, or
exposure to respiratory droplets and secretions), disease
phase of patients to whom they were exposed (during incu-
bation period, early fever, fever and cough, or intubation
period), occurrence of fever (>38°C), and respiratory or
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Serum samples were collected twice from 206 health-
care workers during a 1-month period after the initial
exposure to patients with SARS, with a minimum interval
between collections of 2 weeks. Serologic response to
SARS-CoV was determined by using an indirect immuno-
fluorescence assay (IFA) as described previously (5) and
the immunochromatographic test (ICT, Tyson
BioResearch, Inc, Taiwan). ICT consists of a double-anti-
gen (recombinant viral nucleocapsid antigen) sandwich.
The test gives results within 15 min. Data obtained from
13 patients with severe SARS, as defined by using CDC
criteria (7), showed that the sensitivity of the ICT test was
>90% within 2 weeks of fever onset and 100% after 6
weeks. Data obtained from 51 cases of severe SARS
demonstrated that the sensitivity of either IFA or ICT was
98% after 6 weeks (8). Furthermore, the specificity of each
assay determined by 812 serum samples was 100%.
The Table compares the extent of personal protective
equipment use before and after implementing specific
infection-control measures. Healthcare workers during the
“after” period were substantially more likely than the
“before” period to have used full personal protective
equipment (Table). 
First serum samples were collected 12.4 ± 5.4 days
(mean ± standard deviation) after initial exposure to SARS
patients. Second serum samples were collected 37.2 ± 7.9
days after exposure. Ninety percent were collected >30
days after exposure. None of the 73 healthcare workers
exposed during the before period produced a positive
result on serologic tests for SARS. This group included a
physician who intubated patient 1 and wore two layers of
surgical masks and used inline suction after intubation.
SARS developed in 1 of 150 healthcare workers exposed
during the after period. This healthcare worker was a chest
physician. On March 17, he performed a 30-min chest
sonogram on patient 2 in a negative-pressure isolation
room and wore an N-95 respirator, double gloves, gown,
disposable cap, and shoe covers. On the same day, he
helped intubate patient 2 while positioned approximately 3
feet from the patient’s head. During this period, patient 2
was irritable and had a vigorous cough. The physician
recalled that he had not tried the mask on or confirmed that
it was air-tight before entering the isolation room. Fever
developed 4 days later in this physician, designated as
patient 6, and pneumonia developed 5 days after that. Both
virus culture and reverse transcriptase–polymerase chain
reaction (RT-PCR) demonstrated SARS-CoV in the spu-
tum. Immunoglobulin (Ig) G against SARS-CoV deter-
mined by IFA was >1:1,000 (5). After this experience, the
infection-control team reemphasized the importance of fit-
testing facemasks and recommended wearing a face shield
when in close contact with SARS patients. SARS did not
develop in another physician who intubated patient 2 and
four nurses who assisted the procedure in the same room.
Conclusions
In this study, a physician who intubated a patient with
SARS while following standard precautions did not
become ill, but SARS developed in another physician
whose N95 respirator was not properly fit-tested. A sero-
logic response to SARS-CoV could not be demonstrated in
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Table. Personal protection before and after recognizing severe acute respiratory syndrome (SARS) and implementing specific 
infection-control measures at the National Taiwan University Hospital 
  Exposure type 
 
In the same room
a  Direct contact 
Exposure to respiratory droplets and 
secretions 
Protective 
measures 
Before   
(n = 73) 
After   
(n =155)  p value 
Before 
  (n = 46) 
After   
(n = 132)  p value 
Before   
(n = 37) 
After   
(n = 92)  p value 
Masks      <0.001      <0.001      <0.001 
None  36  0    20  0    17  0   
Surgical mask, 
N95 or P100 
respirator 
37  155    26  132    20  92   
Gloves      <0.001      <0.001      <0.001 
None  57  7    28  4    17  2   
One- or two-layer  16  148    18  128    20  90   
Eye protection      <0.001      <0.001      <0.001 
None  73  117    46  99    37  66   
Glasses, goggles, 
or face shields 
0  38    0  33    0  26   
Gowns      <0.001      <0.001      <0.001 
None  66  6    38  6    30  3   
One- or two-layer    7  149    8  126    7  89   
aFive healthcare workers stayed in the same room with SARS patients before and after implementation of specific infection-control measures. Among 223 healthcare 
workers, 178 had direct contract to SARS patients or their environment, and 129 had exposure to respiratory droplets and secretions. 205 healthcare workers who spent time in the same room
as or had direct contact with SARS patients.
The major question that arises from this study is why 36
(50%) healthcare workers who stayed in the same room
with SARS patients before the outbreak was recognized
and who did not wear masks were not infected. Several
possible explanations exist. Patient 2 wore a face mask
when she visited the emergency room. The physician who
intubated patient 1 was alert, wore two layers of surgical
masks, and followed standard precautions. Inline suction
was routinely performed at the hospital for intubated
patients to prevent aerosol formation; therefore, unprotect-
ed healthcare workers might not have been exposed to a
sufficient amount of SARS-CoV to produce a systemic
infection. An alternate explanation could be that existing
serologic assays are not sufficiently sensitive to identify
subclinical infections. This explanation is unlikely, howev-
er, because the tests we used have been shown to be high-
ly sensitive and specific in patients with SARS (5,8), and
90% of convalescent-phase serum samples were collected
>30 days after exposure. Yet another explanation could be
that SARS-CoV is attenuated by serial passage in humans.
This explanation is also unlikely since SARS developed in
the five index patients admitted to the hospital in the early
phase of the epidemic and in one physician with a poorly
fitting mask. Further, phylogenetic tree analysis (9) indi-
cates that patients 2, 3, and 6 were infected by strains relat-
ed to the large outbreak in Amoy Gardens in Hong Kong
(2), and patients 4 and 5 were infected by strains related to
a large hospital outbreak in Taipei (10). Afinal explanation
could be, simply, that the disease does not develop in all
people exposed to the virus. 
Transmission of SARS was limited initially at our hos-
pital (attack rate 0.4%) when healthcare workers followed
standard precautions or specific infection-control meas-
ures, including droplet and contact precautions. However,
in later stages of the epidemic, SARS was more likely to
develop in healthcare workers, despite similar or higher
levels of personal protective equipment use. Although one
possible explanation for this could have been exposure to
unrecognized SARS patients, contamination of the envi-
ronment leading to indirect contact transmission may have
also played a role (11).
In conclusion, while SARS-CoV can spread rapidly in
a nonimmune human population (1–3), this study demon-
strated infrequent transmission of SARS to healthcare
workers caring for the first five SARS patients in Taiwan,
despite a number of unprotected exposures. Nonetheless,
given that SARS has, on other occasions, shown itself to
be highly transmissible (1–3,10), we still recommend strict
precautions (1–3,11–14).
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